{"id":"NCT01664949","sponsor":"Allergan","briefTitle":"A Study to Compare the Safety and Efficacy of A New Eye Drop Formulation With OPTIVE™ in Subjects With Dry Eye Disease","officialTitle":null,"status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-01","primaryCompletion":"2014-05","completion":"2014-05","firstPosted":"2012-08-14","resultsPosted":"2015-06-08","lastUpdate":"2015-09-21"},"enrollment":460,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Dry Eye Disease"],"interventions":[{"type":"DRUG","name":"Carboxymethylcellulose Based Eye Drop Formulation A","otherNames":[]},{"type":"DRUG","name":"Carboxymethylcellulose Based Preservative-Free Lubricant Eye Drops","otherNames":["REFRESH OPTIVE™","OPTAVA™"]}],"arms":[{"label":"Carboxymethylcellulose Based Eye Drop Formulation A","type":"EXPERIMENTAL"},{"label":"OPTIVE™","type":"ACTIVE_COMPARATOR"}],"summary":"This study will evaluate the safety and efficacy of a carboxymethylcellulose based eye drop formulation compared with carboxymethylcellulose based preservative-free lubricant eye drops (OPTIVE™) in subjects with dry eye disease.","primaryOutcome":{"measure":"Change From Baseline in Ocular Surface Disease Index (OSDI) Score at Day 90","timeFrame":"Baseline, Day 90","effectByArm":[{"arm":"Carboxymethylcellulose Based Eye Drop Formulation A","deltaMin":41.77,"sd":14.018},{"arm":"OPTIVE™","deltaMin":40.92,"sd":13.31}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":3},"locations":{"siteCount":12,"countries":["Australia","Belgium","France","Germany","Italy","Russia","Spain","United Kingdom"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":5,"n":224},"commonTop":["Eye irritation"]}}